Human Xtensions

Human Xtensions Equity

The The Equity of Human Xtensions (HUMX-M.TA) as of Oct 31, 2026 is 2.91 M ILS. In the previous year, The Equity was 26.11 M ILS — a change of -88.84% (lower).

Equity

2.91 MILS

YoY

-88.84%

Last updated:

In 2024, Human Xtensions's equity was 2.91 M ILS, a -88.84% increase from the 26.11 M ILS equity in the previous year.

The Human Xtensions Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
15.51 M ILS
Jan 1, 2019
20.43 M ILS
Jan 1, 2020
148.82 M ILS
Jan 1, 2021
104.53 M ILS
Jan 1, 2022
61.78 M ILS
Jan 1, 2023
26.11 M ILS
Jan 1, 2024
2.91 M ILS
The Human Xtensions Equity history
YEAREquityYoY
2.91 MILS-88.84%
26.11 MILS-57.74%
61.78 MILS-40.90%
104.53 MILS-29.76%
148.82 MILS+628.49%
20.43 MILS+31.76%
15.51 MILS—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Human Xtensions Stock analysis

What does Human Xtensions do? Human Xtensions Ltd. develops and sells medical devices for minimally invasive surgery, including HandX, Fenestrated Gasper, Monopolar Hook, and Needle Holder. The company focuses on digital handheld devices that extend the human hand, providing surgeons with ergonomic positioning during procedures. Its products are marketed globally to healthcare providers and surgical teams seeking advanced tools for laparoscopic operations. The firm operates through its subsidiary Human Xtensions Inc. to serve international markets. The company's revenue comes from the sale of its product portfolio, with HandX being an electromechanical laparoscopic device designed for controlled surgical procedures. Fenestrated Gasper, Monopolar Hook, and Needle Holder complement the HandX system, targeting specific surgical applications. These products are sold directly to hospitals and surgical centers worldwide, with no mention of additional services or licensing agreements in the business description. Human Xtensions Ltd. serves the global medical device market, specifically focusing on minimally invasive surgical tools. The firm's products are designed to improve surgeon ergonomics and patient outcomes during laparoscopic procedures. Its subsidiary Human Xtensions Inc. supports international sales and distribution, ensuring global reach without specifying regional market segments or customer types beyond healthcare institutions. Human Xtensions is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Human Xtensions's Equity

Human Xtensions's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Human Xtensions's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Human Xtensions's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Human Xtensions's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Human Xtensions’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Human Xtensions stock

The Equity of Human Xtensions is 2.91 M ILS in 2024.

The Equity of Human Xtensions changed from 26.11 M ILS to 2.91 M ILS, representing a -88.84% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Human Xtensions since 2006 – with annual values, charts, and detailed analysis.

The Equity's ILS is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Human Xtensions historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Human Xtensions

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Human Xtensions